Their own payment-practices filing · gov.uk
Merck Sharp & Dohme Limited pays suppliers in 63 days on average — inside its 90-day stated terms
Their H1 2026 filing puts the average 27 days inside their stated 90-day term.
- Their stated terms
- 90 days
- Paid outside agreed terms
- 57% of invoices
- Paid after 61+ days
- 54%
- Reporting period
- 1 Jan 2026 – 30 Jun 2026
- Source
- their gov.uk filing, filed 13 Jul 2026
Self-reported figures from their statutory filing. How this is compiled.
Terms vs reality · their H1 2026 filing
Paid 27 days inside the 90-day term they state
Where their invoices landed · share of all invoices
The pattern · last 6 of 16 reports
104 → 63 days — getting faster
The read · computed from their figures
Merck Sharp & Dohme Limited's H1 2026 filing puts their average at 63 days against stated terms of 90 days; 57% of invoices were paid outside agreed terms and 54% took 61 days or longer. Filed 13 Jul 2026.
The direction is faster: from 104 days in H2 2023 to 63 now — 41 days faster across their last 6 reports.
On the latest reported averages: Slower than 83% of the 977 large companies reporting in manufacturing.
That is 16 statutory periods on record (earliest H1 2018) — a historical record, not a promise for a new invoice.
What they tell their suppliers
In their own words · from the filing
Standard payment terms
90 days with two payment runs per month. Payment terms can be adjusted for SMEs
Dispute resolution
All enquires and complaints can be logged with our dedicated Helpdesk (telephone and email). Issues generallyrelate to incorrect invoice submissions including incorrect amounts, incorrect/missing PO information andincorrect/missing VAT numbers. The metrics of the Helpdesk are reviewed for quality/effectiveness on a monthlybasis. An independently staffed Speak Up Tool provides a forum for suppliers to raise ethical concernsanonymously, though it helps if as much information is provided to resolve the issue/complaint.
Every statutory report on record
Most recent first.
| Period | Avg days | Outside terms | 61+ days | Filed |
|---|---|---|---|---|
| H1 2026 | 63 | 57% | 54% | 13 Jul 2026 |
| H2 2025 | 66 | 55% | 56% | 3 Feb 2026 |
| H1 2025 | 87 | 44% | 81% | 11 Sept 2025 |
| H2 2024 | 96 | 49% | 82% | 31 Jan 2025 |
| H1 2024 | 88 | 32% | 84% | 8 Aug 2024 |
| H2 2023 | 104 | 36% | 88% | 8 Aug 2024 |
| H1 2023 | 50 | 20% | 45% | 24 Nov 2023 |
| H1 2022 | 61 | 14% | 83% | 19 Jul 2022 |
| H2 2021 | 57 | 11% | 84% | 17 Jan 2022 |
| H1 2021 | 63 | 14% | 80% | 16 Jul 2021 |
| H2 2020 | 80 | 9% | 80% | 8 Feb 2021 |
| H1 2020 | 79 | 8% | 79% | 4 Aug 2020 |
| H2 2019 | 61 | 0% | 74% | 13 Feb 2020 |
| H1 2019 | 76 | 9% | 80% | 4 Sept 2019 |
| H2 2018 | 76 | 0% | 79% | 4 Sept 2019 |
| H1 2018 | 76 | 0% | 78% | 4 Sept 2019 |
On the public register · Companies House
Company record
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 25 Sept 1964
- Registered office
- ORGANON PHARMA (UK) LIMITED, CRAMLINGTON, NE23 3JU
Quick answers · Merck Sharp & Dohme Limited
Are they getting slower or faster?
What's their typical pay point?
Can I see what this means for my invoices?
Stay ahead
Watch Merck Sharp & Dohme Limited (free)
Their next payment report is due ≈ 26 Jan 2027. We watch their public record and email you when something changes — a new payment report, late filings, insolvency markers, new charges.
You’ll get a confirmation email first. Unsubscribe any time. How we handle your address.
More large companies in manufacturing
Mercedes Amg High Performance Powertrains Limited · Mercury Pharma Group Limited · Memory Lane Cakes Limited · Mercury Pharmaceuticals Limited · Melitta UK Ltd. · Merial Animal Health Limited
How UK payment reporting works
What is a Payment Practices Report?
What does "paid outside agreed terms" mean?
How often is this data updated?
Is this official government data?
How this is compiled. Built from official records only: Companies House and the gov.uk payment-practices service. The payment figures are self-reported — companies over the size threshold must file them by law and the board signs them off. No credit-agency data. The numbers are theirs; the plain-English read is ours. This is information compiled from public records under the Open Government Licence v3.0 — not a credit rating and not advice.
The 31-day comparison figure is the median across 6,104 companies with a current statutory report — every sector pooled, not an average of sector medians (how the figure is built).
Report PL-00820771 · latest period to 30 Jun 2026
Built by YORXEN LTD · registered in England & Wales · CRN 17303256 · privacy · terms.